Antibodies to type II collagen and HLA disease susceptibility markers in rheumatoid arthritis.
OBJECTIVE
To seek associations between antibodies to native and denatured type II collagen (NCII and DCII) and HLA in rheumatoid arthritis (RA).


METHODS
One hundred fourteen patients with clinically well-defined RA were HLA-DR and DQ typed. Those who were DR4 positive were subtyped for DRB1*0401-*0408 alleles by polymerase chain reaction using allele-specific oligonucleotide probes. Antibodies to human NCII and DCII (heat-denatured) were measured by enzyme-linked immunosorbent assay. The frequency of HLA alleles was compared in patients grouped according to the presence and absence of antibodies to NCII and DCII.


RESULTS
Twenty-seven patients (24%) were positive for antibodies to NCII. There was a significant increase in the frequency of HLA-DR7 in anti-NCII-positive patients compared with anti-NCII-negative patients (30% versus 9%; P = 0.019) and a significant decrease in HLA-DR3 (7% versus 28%; P = 0.044). Repeating the analyses after excluding the 16 patients who were DR7 positive revealed a significant increase in the frequency of HLA-DR1 in anti-NCII-positive patients compared with anti-NCII-negative patients (63% versus 27%; P = 0.045). Moreover, antibodies to NCII were associated with the third hypervariability region susceptibility sequence QRRAA that is present in DRB1*0101, *0404, *0405, and *0408 (84% versus 47%; P = 0.0085); 24 of 27 anti-NCII-positive patients were positive for either DR7, DR1, or DRB1*0404 or *0408. Thirty patients (26%) were positive for antibodies to DCII. There was a significant increase in the frequency of HLA-DR3 in anti-DCII-positive patients compared with anti-DCII-negative patients (40% versus 18%; P = 0.028).


CONCLUSIONS
The genetic associations between HLA-DR alleles and antibodies to CII in RA patients is in keeping with the collagen-induced arthritis model and implicates autoimmunity to CII as a major component in the multifactorial pathogenesis of RA.
Cook
A D
AD
Monash University, Clayton, Victoria, Australia.
Stockman
A
A
Brand
C A
CA
Tait
B D
BD
Mackay
I R
IR
Muirden
K D
KD
Bernard
C C
CC
Rowley
M J
MJ
D000483:Alleles; D000906:Antibodies; D001172:Arthritis, Rheumatoid / Q000276:immunology*; D003094:Collagen / Q000276:immunology*; D004198:Disease Susceptibility / Q000276:immunology*; D020022:Genetic Predisposition to Disease / Q000235:genetics; D005838:Genotype; D006680:HLA Antigens / Q000276:immunology*; D006684:HLA-DR Antigens / Q000235:genetics; D006801:Humans; D011110:Polymorphism, Genetic
D000906:Antibodies; D006680:HLA Antigens; D006684:HLA-DR Antigens; D003094:Collagen